COOPER C. COLLINS - Corporate Board Profile

TherapeuticsMD, Inc.

Filing Date	Source Excerpt
2013-07-12	Cooper C. Collins has served as a director of our company since February 2012... Member of the Compensation Committee... Director Compensation table shows $80,287 option awards for Mr. Collins.
2014-04-17	Cooper C. Collins compensation for the year ended December 31, 2013 was $114,217.
2015-04-30	Cooper C. Collins has served as a director of our company since February 2012. ... The Audit Committee currently consists of Messrs. LaPenta, Jr., Collins, Russell, and Segal, each an independent director of our company under the NYSE MKT rules as well as under rules adopted by the SEC pursuant to the Sarbanes-Oxley Act of 2002. Mr. LaPenta, Jr. serves as the Chairman of the Audit Committee. ... The Compensation Committee currently consists of Messrs. Collins, Carroll, and Thompson, with Mr. Collins serving as Chairman. ... We compensate our directors with a combination of cash and equity. Each director receives an annual base cash retainer of $50,000 for such service and an annual grant of stock options to purchase 45,000 shares of our common stock. ... The following table and accompanying footnotes detail compensation paid to our directors for services rendered for the year ended December 31, 2014. ... Cooper C. Collins $50,000 $216,377 $0 $266,377.
2016-04-28	Cooper C. Collins has served as a director of our company since February 2012. ... We believe Mr. Collins' specialty pharmaceutical company knowledge and executive experience provide the requisite qualifications, skills, perspectives, and experience that make him well qualified to serve on our Board of Directors.
2017-04-25	Cooper C. Collins has served as a director of our company since February 2012. ... Mr. Collins has served as Chief Executive Officer of Fortis BioPharma since June 2015. ... The following table and accompanying footnotes detail compensation paid to our directors for services rendered for the year ended December 31, 2016. Cooper C. Collins $83,500 fees earned or paid in cash, $89,503 option awards, total $173,003.
2018-04-27	Cooper C. Collins has served as a director of our company since February 2012. ... The Audit Committee currently consists of Messrs. LaPenta, Jr., Segal, Collins, and Russell. ... The Compensation Committee currently consists of Messrs. Collins, Thompson, and Carroll, with Mr. Collins serving as Chairman. ... Cooper C. Collins Fees Earned or Paid in Cash: $83,500, Option Awards: $165,115, Total: $248,615.
2019-04-30	Cooper C. Collins has served as a director of our company since February 2012. ... Member of the Compensation Committee. Member of the Audit Committee. ... Director Compensation table shows $92,500 fees earned in cash and $180,039 option awards, total $272,539.
2020-05-04	Cooper C. Collins has served as a director of our company since February 2012. ... Mr. Collins received a B.A. from Nicholls State University, where he later received an M.B.A.
2021-04-14	Cooper C. Collins has served as a director of our company since February 2012. Mr. Collins has served as Chief Executive Officer of Fortis BioPharma LLC since June 2015. Mr. Collins served as Chief Strategy Officer of Pernix Therapeutics Holdings, Inc. [NASDAQ: PTX], or Pernix, from May 2013 until April 2014, as its President and Chief Executive Officer from March 2010 until May 2013, and as a director from March 2010 until February 2014. Mr. Collins joined Pernix Therapeutics, Inc., a predecessor of Pernix, in 2002, where he was appointed as a director in January 2007, its President in December 2007 and its Chief Executive Officer in June 2008, serving in those three capacities until March 2010. From December 2005 to December 2007, Mr. Collins served as Vice President of Business and Product Development of Pernix Therapeutics, Inc. and as its Territory Manager from December 2003 to December 2005. Mr. Collins was employed for three years by the National Football League franchise, the New Orleans Saints, in its media relations department.
2023-05-17	Cooper C. Collins has served as a director of our Company since February 2012. ... Committees: Audit, Compensation ... The Audit Committee currently consists of Messrs. Collins, Thompson and Roberts, each an independent director ... The Compensation Committee currently consists of Dr. Naughton and Messrs. Collins and Roberts ... The following table and accompanying footnotes detail compensation paid to our directors for services rendered for the year ended December 31, 2022. ... Cooper C. Collins 92,000 Fees Earned or Paid in Cash, 33,650 Stock Awards, Total 125,650.
2024-10-25	Cooper C. Collins has served as a director of our Company since February 2012.